Startseite

Aktien

Unicycive Therapeutics

Nachrichten

Unicycive Therapeutics Aktie

Aktie

ISIN: US90466Y2028 WKN: A4195L SYM: UNCY Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

5,8800

USD

0,00 %

0,0000 USD

Letzter Kurs 02:00:00 Nasdaq

Unicycive Therapeutics Aktie kaufen

Geldkurs

16.12.25

5,8700

USD

2.700 STK

Briefkurs

16.12.25

5,8900

USD

200 STK

Verkauf

Kauf

Hinweis
Verlängerte Handelszeiten
Ab sofort von 07:30 bis 23:00 Uhr

Neueste Nachrichten

Important Notice to Long-term Shareholders of Unicycive Therapeutics, Inc. (UNCY): Grabar Law Office Is Investigating Claims on Your Behalf 01.12.25 · newsfile · Unicycive Therapeutics
Important Notice to Long-Term Shareholders of Unicycive Therapeutics, Inc. (UNCY): Grabar Law Office Investigates Claims on Your Behalf 03.11.25 · newsfile · Unicycive Therapeutics
Important Notice to Long-Term Shareholders of Unicycive Therapeutics, Inc. (UNCY): Grabar Law Office Investigates Claims on Your Behalf 15.10.25 · newsfile · Unicycive Therapeutics
UNCY Deadline Today: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights 14.10.25 · Business Wire (engl.) · Unicycive Therapeutics
Did You Lose Money on Unicycive Therapeutics, Inc. (UNCY)? Levi & Korsinsky Urges Investors to Act Before October 14, 2025 14.10.25 · newsfile · Unicycive Therapeutics
UNCY INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics 14.10.25 · newsfile · Unicycive Therapeutics
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important October 14 Deadline in Securities Fraud Lawsuit - UNCY 14.10.25 · newsfile · Unicycive Therapeutics
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics 13.10.25 · Business Wire (engl.) · Unicycive Therapeutics
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important October 14 Deadline in Securities Fraud Lawsuit - UNCY 12.10.25 · newsfile · Unicycive Therapeutics
Faruqi & Faruqi Reminds Unicycive Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2025 - UNCY 11.10.25 · newsfile · Unicycive Therapeutics
ROSEN, A TOP RANKED LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important October 14 Deadline in Securities Fraud Lawsuit - UNCY 11.10.25 · newsfile · Unicycive Therapeutics
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Contact Levi & Korsinsky Before October 14, 2025 to Join Class Action 10.10.25 · newsfile · Unicycive Therapeutics

1
2
3
4
5
…
8

Important Notice to Long-term Shareholders of Unicycive Therapeutics, Inc. (UNCY): Grabar Law ... 124 Leser

Unicycive Therapeutics Announces Publication of Oxylanthanum Carbonate (OLC) Positive ... 184 Leser
Unicycive Therapeutics Announces the Publication of Preclinical Data on Synergies Between ... 184 Leser
Unicycive Therapeutics Announces the Publication of Patient Perspectives on Phosphate Management in ... 160 Leser
Unicycive to Highlight Patient Reported Outcomes Data at Upcoming Medical Meetings Showing ... 152 Leser
Faruqi & Faruqi Reminds Unicycive Investors of the Pending Class Action Lawsuit with a Lead ... 140 Leser
ROSEN, LEADING INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure ... 140 Leser
Unicycive Therapeutics, Inc. Announces Reverse Stock Split 140 Leser
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive ... 136 Leser
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure ... 136 Leser
ROSEN, A TOP RANKED LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel ... 136 Leser